Robert Buckley Biography and Net Worth

Mr. Buckley was appointed the Company’s Chief Financial Officer on March 31, 2011. Prior to joining the Company in February 2011, Mr. Buckley had a ten-year career with PerkinElmer, Inc. (“PerkinElmer”), a provider of technology and services to the diagnostics, research, environmental, safety and security, industrial and laboratory services markets, where he served in several financial positions of increasing responsibilities. From September 2008 to February 2011, Mr. Buckley served as Vice President and Chief Financial Officer of PerkinElmer’s Environmental Health business. From September 2005 to September 2008, Mr. Buckley was Chief Financial Officer of PerkinElmer’s Asian operations. From April 2001 to August 2005, Mr. Buckley served in various financial management roles at PerkinElmer. Prior to joining PerkinElmer, Mr. Buckley held management positions with Honeywell International, Inc., a diversified technology and manufacturing company that services customers globally, and Georgeson & Company, Inc. Mr. Buckley holds a Bachelor of Arts degree in Finance from Manhattanville College and an M.B.A. from University of California at Los Angeles (U.C.L.A.). Provided by Tagnifi.

What is Robert Buckley's net worth?: The estimated net worth of Robert Buckley is at least $18.07 million as of February 29th, 2024. Mr. Buckley owns 120,419 shares of Novanta stock worth more than $18,065,258 as of April 19th. This net worth estimate does not reflect any other assets that Mr. Buckley may own. Additionally, Mr. Buckley receives a salary of $1,200,000.00 as CFO at Novanta. Learn More about Robert Buckley's net worth.
How old is Robert Buckley?: Mr. Buckley is currently 50 years old. There are 3 older executives and no younger executives at Novanta. The oldest executive at Novanta is Mr. Peter L. Chang, Corporate Controller & Chief Accounting Officer, who is 59 years old. Learn More on Robert Buckley's age.
What is Robert Buckley's salary?: As the CFO of Novanta Inc., Mr. Buckley earns $1,200,000.00 per year. The highest earning executive at Novanta is Mr. Matthijs Glastra, CEO & Chairman of the Board, who commands a salary of $2,620,000.00 per year. Learn More on Robert Buckley's salary.
How do I contact Robert Buckley?: The corporate mailing address for Mr. Buckley and other Novanta executives is 125 Middlesex Turnpike, Bedford MA, 01730. Novanta can also be reached via phone at (781) 266-5700 and via email at [email protected]. Learn More on Robert Buckley's contact information.
Has Robert Buckley been buying or selling shares of Novanta?: Robert Buckley has not been actively trading shares of Novanta during the past quarter. Most recently, Robert Buckley sold 3,000 shares of the business's stock in a transaction on Thursday, February 29th. The shares were sold at an average price of $170.40, for a transaction totalling $511,200.00. Following the completion of the sale, the chief financial officer now directly owns 120,419 shares of the company's stock, valued at $20,519,397.60. Learn More on Robert Buckley's trading history.
Who are Novanta's active insiders?: Novanta's insider roster includes Robert Buckley (CFO), Peter Chang (CAO), Matthijs Glastra (CEO), Thomas Secor (Director), and Brian Young (Insider). Learn More on Novanta's active insiders.
Are insiders buying or selling shares of Novanta?: In the last twelve months, insiders at the technology company sold shares 10 times. They sold a total of 27,400 shares worth more than $4,471,657.00. The most recent insider tranaction occured on April, 1st when CEO Matthijs Glastra sold 5,000 shares worth more than $860,000.00. Insiders at Novanta own 1.2% of the company. Learn More about insider trades at Novanta.
Information on this page was last updated on 4/1/2024.

Robert Buckley Insider Trading History at Novanta

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/29/2024	Sell	3,000	$170.40	$511,200.00	120,419
2/7/2024	Sell	1,500	$160.23	$240,345.00	120,159
2/1/2024	Sell	1,500	$156.41	$234,615.00	121,659
1/2/2024	Sell	3,000	$163.91	$491,730.00	118,556
12/18/2023	Sell	900	$170.08	$153,072.00	126,656
12/6/2023	Sell	3,000	$150.87	$452,610.00	132,056
10/16/2023	Sell	1,500	$150.39	$225,585.00	135,056
9/7/2023	Sell	3,000	$160.20	$480,600.00	136,556
1/13/2023	Sell	1,667	$150.00	$250,050.00	133,585
1/9/2023	Sell	2,380	$141.06	$335,722.80	136,228
12/28/2022	Sell	216	$140.18	$30,278.88	133,813
11/28/2022	Sell	4,703	$157.10	$738,841.30	134,029
11/8/2022	Sell	3,334	$150.00	$500,100.00	138,732
10/28/2022	Sell	7,144	$140.00	$1,000,160.00	142,066
8/23/2021	Sell	8,363	$147.36	$1,232,371.68	153,390
8/19/2021	Sell	48	$148.57	$7,131.36	157,059
4/26/2021	Sell	3,572	$140.19	$500,758.68	153,860
4/5/2021	Sell	3,704	$136.02	$503,818.08	158,198
11/16/2020	Sell	4,000	$115.08	$460,320.00	152,681
7/15/2020	Sell	9,564	$104.92	$1,003,454.88	166,245
4/27/2020	Sell	5,883	$86.06	$506,290.98	169,015
1/15/2020	Sell	5,260	$94.82	$498,753.20	163,321
7/8/2019	Sell	16,277	$91.06	$1,482,183.62	158,803
9/17/2018	Sell	13,487	$72.90	$983,202.30	157,027
3/19/2018	Sell	8,780	$55.95	$491,241.00	166,643
3/12/2018	Sell	8,764	$56.83	$498,058.12
3/5/2018	Sell	8,850	$55.55	$491,617.50	184,187
5/16/2016	Sell	9,000	$15.00	$135,000.00	169,188
5/14/2015	Sell	8,100	$14.66	$118,746.00
5/9/2014	Sell	20,000	$12.37	$247,400.00	117,183

Robert Buckley Buying and Selling Activity at Novanta

Novanta Company Overview

Novanta Inc., together with its subsidiaries, provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally. The company operates through three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. The Precision Medicine and Manufacturing segment offers photonics-based solutions, including laser scanning, beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products serving photonics-based applications for industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; wireless technologies, video recorders, and video integration technologies for operating room integrations; optical data collection and machine vision technologies; radio frequency identification technologies; thermal chart recorders; spectrometry technologies; and embedded touch screen solutions. The Robotics and Automation segment offers optical and inductive encoders, precision motors, servo drives and motion control solutions, integrated stepper motors, intelligent robotic end-of-arm technology solutions, air bearings, and air bearing spindles. The company sells its products through its direct sales force and distributors under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, General Scanning, ATI Industrial Automation, Celera Motion, IMS, MicroE, Applimotion, Zettlex, Ingenia, and Westwind brands. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is headquartered in Bedford, Massachusetts.

Today's Range

Now: $149.41

$146.86

$150.67

50 Day Range

MA: $167.62

$150.02

$178.38

2 Week Range

Now: $149.41

$111.20

$187.60

Volume

161,046 shs

Average Volume

130,670 shs

Market Capitalization

$5.36 billion

P/E Ratio

73.60

Dividend Yield

N/A

Beta

1.33

Forget NVIDIA, buy this $2 AI stock now…

From Behind the Markets | Ad

This company is at the center of a trillion-dollar industry, fighting for a piece of a massive $20 billion pentagon contract.

Click here to learn more >>>

Robert Buckley Biography and Net Worth

What is Robert Buckley's net worth?

How old is Robert Buckley?

What is Robert Buckley's salary?

How do I contact Robert Buckley?

Has Robert Buckley been buying or selling shares of Novanta?

Who are Novanta's active insiders?

Are insiders buying or selling shares of Novanta?